Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Nov 28;11:106. doi: 10.1186/s12977-014-0106-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Etemad et al.; licensee BioMed Central Ltd. 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Viruses with envelopes from different phases of infection demonstrate similar replication in α4β7 high CD4+ T cells. Scatter plots show relative light units in TZM-bl cells infected with 50 ul of virus supernatants recovered from virus exposed FACS confirmed α4β7 high CD4+ T cells (A – D). Each symbol represents mean of 3 independent RLU measurements. Scatter plots show number of RNA copies recovered from virus exposed FACS confirmed α4β7 high CD8+ T cells from 4 different HIV-1 seronegative donors (E - H). Each symbol represents mean of 2 independent RNA copy quantifications. Similar to Figure 2, in the early and chronic group unique symbols are used to show the longitudinal changes within an injection drug user. In each scatterplot, the lines denote the median. Significant differences (p ≤0.05) are indicated with a star in the graphs. Symbols in gray denote virus stocks shown to be able to utilize the CXCR4 receptor.